Back to Search
ELIZABETH STOCK, M.D.
M.D.
Obstetrics & Gynecology Physician
NPI: 1104274695IndividualAccepts Medicare
Education
UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Class of 2016
Research & Publications (12)
Non-classical light emission from a single electrically driven quantum dot.
PMID 19547250·Opt Express·2007
8-other
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
PMID 17414241·J Clin Psychopharmacol·2007
4-observational
Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
PMID 17076982·Curr Med Res Opin·2006
2-rct
Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
PMID 16953381·Psychopharmacology (Berl)·2006
4-observational
A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA).
PMID 16483745·Schizophr Res·2006
4-observational
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.
PMID 16401666·J Psychopharmacol·2006
4-observational
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial.
PMID 16135860·Br J Psychiatry·2005
4-observational
A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
PMID 15600384·J Clin Psychiatry·2004
3-trial
Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study.
PMID 14628980·J Clin Psychiatry·2003
3-trial
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
PMID 12860772·Arch Gen Psychiatry·2003
3-trial
Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials.
PMID 12729864·Schizophr Res·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5323 HARRY HINES BLVD
DALLAS, TX 75390 - Phone
- (214) 648-3026
Quick Facts
- NPI
- 1104274695
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 10
- Publications
- 12
Are you this provider?
Claim Your Profile